Merck & Co Inc
NYSE: MRK
$117.17
-$0.06 (-0.1%)
Closing Price on September 20, 2024
MRK Articles
The November 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was up.
Published:
Last Updated:
December 3, 2015: Markets opened slightly higher on Thursday but any inference that equities were in for a good day were soon crushed as stocks turned south and have traded lower for virtually all...
Published:
Last Updated:
December 1, 2015: Markets opened higher on again on Tuesday and, unlike yesterday, held on to the gains for the most of the day. Equities took their cue from markets in Asia and Europe, both broadly...
Published:
Last Updated:
November 30, 2015: Markets opened higher on Monday but the upbeat start to the day didn’t last long. Industrials and consumer discretionary stocks weighed most heavily on equity indexes today, with...
Published:
Last Updated:
November 27, 2015: Markets opened mixed on Friday but only narrowly up or down from Wednesday’s close. No economic data was due out today and there was little corporate news as well. A stronger...
Published:
Last Updated:
Despite the howling from political candidates trying to make the top drug-makers their whipping boy in populist campaign efforts, the need and demand for pharmaceuticals will only continue. This...
Published:
Last Updated:
Tuesday's top analyst upgrades, downgrades and initiations include Antero Resources, Athenahealth, Capstone Turbine, Clovis Oncology, Genworth Financial, Merck, Nuance Communications and...
Published:
Last Updated:
Merck is joining the likes of Gilead Sciences in producing hepatitis C vaccines, but it is still in the early clinical stages.
Published:
Last Updated:
November 11, 2015: Markets opened up on Wednesday but over the course of the day the markets drifted lower to close the day marginally negative. The dollar gained only slightly while equities traded...
Published:
Last Updated:
The short interest data have been released for the October 30 settlement date, and for most of the selected pharmaceutical stocks, short interest was down.
Published:
Last Updated:
ThinkstockOctober 28, 2015: Markets opened higher on Wednesday and bounced of intra-day lows following the FOMC announcement which led investors to believe that interest rates may rise in December....
Published:
Last Updated:
Pfizer and Merck both released their third-quarter earnings on Tuesday morning. So, which drug giant is looking better after earnings?
Published:
Last Updated:
The October 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was mixed.
Published:
Merckis expected to report its third-quarter financial results before the markets open on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Apple, Exxon and some of the major Dow Jones Industrial Average companies that are reporting their quarterly results this week.
Published: